PHARMAREVIEW LIMITED

Company number 07796206 · Active

PHARMAREVIEW LIMITED is a private limited company registered in READING, United Kingdom, incorporated on 4 Oct 2011. Its registered activity is other professional, scientific and technical activities n.e.c.. Its latest published accounts for the period ending 31 Dec 2025 show equity of £48.1m, total assets of £48.1m, turnover of £6.0m, a result of £47.8m. It has filed 6 sets of accounts. Our model estimates a 0.01 % probability that it becomes insolvent within 12 months, 0.0 times the average for active companies (low risk).

Insolvency risk, next 12 months

0.01 %
Low risk
Lowest riskHighest risk

Higher than 80 % of active companies in the United Kingdom. 0.0× the average annual insolvency rate (0.12 %).

Raises the risk

Employees7.0×≥ 8 · 0.81 % became insolvent
Turnover (log)5.6×6.00802–7.22806 · 0.65 % became insolvent
Cash ÷ assets4.9×< 0.00304687 · 0.57 % became insolvent
Company age (years)3.3×12.986–22.502 · 0.38 % became insolvent
Total assets (log)3.1×≥ 6.05274 · 0.37 % became insolvent
Turnover growth2.4×-0.576113–-0.214514 · 0.28 % became insolvent

Lowers the risk

Current liabilities ÷ assets0.3×< 0.010552 · 0.03 % became insolvent
Accounts filed0.3×≥ 6 · 0.04 % became insolvent
Equity ratio0.5×≥ 1 · 0.06 % became insolvent
Region0.6×RG · 0.07 % became insolvent
Return on assets0.6×≥ 0.955594 · 0.07 % became insolvent
Operating margin0.7×≥ 0.444175 · 0.09 % became insolvent

Each factor compares companies in the same group (for example the same age band) with the average. The score is a statistical estimate from public data (model AUC 0.99, trained 8 Nov 2026), not a credit rating. How it works.

Company details

Company number
07796206 · official register
Status
Active
Legal form
Private Limited Company
Incorporated
4 Oct 2011 (15 years)
Registered address
RG1 3JH READING
Postcode area
Reading
Activity
74909 Other professional, scientific and technical activities n.e.c.
Industry
Other professional, scientific and technical activities
Accounts overdue
No

Insolvency and register events

No insolvency or liquidation events on record.

Annual accounts GBP

Period endPublishedTurnoverResultEquityTotal assetsCurrent liabilitiesCashEmployees
31 Dec 202521 Aug 2026£6.0m £47.8m£48.1m£48.1m £0£028
31 Dec 202415 Aug 2025£10.5m £5.2m£6.8m£8.8m £2.0m£5.3m73
31 Dec 202315 Aug 2024– £2.0m£5.1m£6.1m £1.0m£2.0m94
31 Dec 202215 Jul 2023– £2.9m£3.1m£4.3m £1.2m£1.6m63
31 Dec 202015 Apr 2021– –£1.4m£1.9m £498k£934k34
31 Dec 201915 Sep 2020– –£818k£1.2m £411k£348k18

As published. Small companies often file a balance sheet only, so turnover and result can be missing.

Similar companies in Reading

Questions about PHARMAREVIEW LIMITED

What is the company number of PHARMAREVIEW LIMITED?

PHARMAREVIEW LIMITED is registered under company number 07796206 in the official register of United Kingdom. View it at the official register.

Is PHARMAREVIEW LIMITED still active?

Yes. PHARMAREVIEW LIMITED is registered as active (status: Active).

Has PHARMAREVIEW LIMITED gone bankrupt or into insolvency?

No insolvency, bankruptcy or administration is recorded for PHARMAREVIEW LIMITED in the official data.

How likely is PHARMAREVIEW LIMITED to become insolvent?

Our model estimates a 0.01 % probability that PHARMAREVIEW LIMITED becomes insolvent within the next 12 months (low risk). That is higher than 80 % of active companies in the United Kingdom.

When was PHARMAREVIEW LIMITED founded?

PHARMAREVIEW LIMITED was incorporated on 4 Oct 2011.

Where is PHARMAREVIEW LIMITED registered?

PHARMAREVIEW LIMITED's registered address is in RG1 3JH READING (Reading), United Kingdom.

What do the latest accounts of PHARMAREVIEW LIMITED show?

The latest published accounts (period ending 31 Dec 2025) show equity of £48.1m, total assets of £48.1m, turnover of £6.0m, a result of £47.8m, 28 employees.

Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 9 Nov 2026.